Status:
COMPLETED
Study of ORL-1F (L-fucose) in Patients With Leukocyte Adhesion Deficiency Type II
Lead Sponsor:
Orpha Labs
Conditions:
Leukocyte Adhesion Deficiency, Type II
Eligibility:
All Genders
Up to 18 years
Phase:
PHASE1
PHASE2
Brief Summary
Study of ORL-1F in Patients With Leukocyte Adhesion Deficiency Type II
Eligibility Criteria
Inclusion
- Diagnosis of Leukocyte Adhesion Deficiency Type II.
- Less than 18 years old.
Exclusion
- Diagnosis of any other disease that is not a manifestation of Leukocyte Adhesion Deficiency Type II.
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2018
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT03354533
Start Date
January 1 2012
End Date
November 1 2018
Last Update
January 25 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.